title: Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol.
abstract: OBJECTIVE
  To review the benefits of statins in coronary artery disease management beyond their cholesterol-lowering effects.
  
  
  METHODS
  A MEDLINE search (1966-May 2000) was conducted using the following terms: lovastatin, pravastatin, simvastatin, atorvastatin, fluvastatin, cerivastatin, endothelium, plaque stabilization, antithrombotic effects.
  
  
  METHODS
  English-language human studies and case reports.
  
  
  METHODS
  Studies published demonstrating other mechanisms of statins' clinical beneficial effects were evaluated and reviewed.
  
  
  RESULTS
  The understanding of the pharmacologic effects of statins has led to the realization that the benefits of these agents extend beyond simply lowering cholesterol. These properties include beneficial effects on vessel endothelial tissue; decreased low-density lipoprotein oxidation and inflammation; ability to stabilize atherosclerotic plaques and perhaps promote regression; proliferative effects on smooth-muscle growths, possibly strengthening atherosclerotic plaques; antithrombotic effects by inhibiting platelet aggregation and stimulation of fibrinolytic factors; and improvement of blood viscosity and flow. With these actions, statins may benefit the situation of long-term atherosclerotic plaque formation and the setting of acute coronary syndrome.
  
  
  CONCLUSIONS
  Further large-scale studies are needed to determine the clinical importance and validity of these postulated beneficial effects of statins.
authors.affiliation: Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY 11201-5372, USA.
authors.forename: C G
authors.initials: CG
authors.lastname: Sotiriou
authors.forename: J W
authors.initials: JW
authors.lastname: Cheng
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism*; D003327:Coronary Disease / Q000378:metabolism / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D008148:Lovastatin / Q000494:pharmacology / Q000627:therapeutic use*; D009130:Muscle, Smooth / Q000187:drug effects; D017035:Pravastatin / Q000494:pharmacology / Q000627:therapeutic use*; D019821:Simvastatin / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin; D017035:Pravastatin